This is a heartening wholesome story. I'm so glad they were able...

This is a heartening wholesome story. I'm so glad they were able to access the treatment.

I know roll-outs can be complex, but hearing Rushin's perspective of getting Daybue being "the hardest thing she's ever done" concerns me, just a little.

From March 17 (approval date) to the time the article was published, June 17, was 3 months of waiting.

I hope, as months go by, this timeframe tightens further, so that they wait weeks instead of months instead.

Thinking of the people who are waiting, it must feel like forever to know that treatment is closer than ever, but also a three month delay to access daybue will reflect in earnings reports too, and it gives high conviction holders opportunities to buy more, while other players engage in short term share price games...